Compound ID | 34
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Burkholderia cepacia complex and most Enterobacteriaceae |
| Institute where first reported: | Institute for Infectious Diseases- University of Bern, Bern, Switzerland |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |